UBS Maintains Buy on Omega Healthcare Invts, Raises Price Target to $54

أوميغا للرعاية الصحية

Omega Healthcare Investors, Inc.

OHI

0.00

UBS analyst Michael Goldsmith maintains Omega Healthcare Invts (NYSE: OHI) with a Buy and raises the price target from $52 to $54.